The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the AT 1 receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT 1 receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. Here, we investigated the role of the first and fourth transmembrane domains (TMDs) in the formation of the binding pocket of the human AT 1 receptor using the substituted-cysteine accessibility method. Each residue within the Phe-28( The octapeptide hormone angiotensin II (AngII) 4 is the active component of the renin-angiotensin system. It exerts a wide variety of physiological effects, including vascular contraction, aldosterone secretion, neuronal activation, and cardiovascular cell growth and proliferation (1, 2). Virtually all the known physiological effects of AngII are produced through the activation of the AT 1 receptor, which belongs to the G proteincoupled receptor (GPCR) superfamily (3, 4). The AT 1 receptor belongs to the rhodopsin-like family A of G protein-coupled receptors, which have a seven-transmembrane helix structure, an extracellular N-terminal tail, an intracellular C-terminal domain, and three extracellular and three intracellular loops.The seven transmembrane domains (TMDs) of GPCRs constitute structural support for signal transduction. Like other family A GPCRs such as rhodopsin and adrenergic receptors, the AT 1 receptor undergoes spontaneous isomerization between its inactive state and its active state (5). Movement of TMD helices through translational or rotational displacement is believed to be essential to achieve the active state (6 -8). These conformational changes would sustain GTP/GDP exchange on specific guanine nucleotide-binding proteins (G proteins) leading to activation of intracellular signaling cascades (5). For the AT 1 receptor, it has been proposed that TMD3, TMD5, TMD6, and TMD7 may participate in the activation process by providing a network of interactions throughout the AngII-binding pocket (9). The dynamics of this network would require that, following agonist binding, novel or existing interactions between the TMDs would either be created or broken, respectively.Based on homology with the recent high resolution structures of the 1 adrenergic, 2 adrenergic, and A 2A adenosine receptors (10 -12) it was expected that the binding site of the AT 1 receptor would be formed between its seven, mostly hydrophobic transmembrane domains and would be accessible to charged water-soluble agonists, like AngII. For this receptor, the binding site would thus be contained within a hydrophilic crevice, the binding pocket, extending from the extracellular surface of the receptor to the transmembrane portions. Because all crystallized structures to date suggest that TMD1 and TMD4 are somewhat removed from the binding pocket (13) The substituted-cysteine accessibility method (SCAM) (20 -22) is an ingenious ap...